Amit Rakhit

Amit Rakhit, M.D., MBA, is a member of Ovid Therapeutic’s Scientific & Clinical Advisory Board. Previously, Rakhit served as president and chief medical officer at Ovid Therapeutics from April 2016 to August 2021. Prior to joining Ovid, Dr. Rakhit served as senior vice president of Worldwide Medical at Biogen Inc. (NASDAQ: BIIB) from March 2014 to March 2016, and as vice president of Program Leadership and Management from June 2011 to February 2014. During that time, he worked on neurologic and hematologic conditions such as: spinal muscular atrophy, amyotrophic lateral sclerosis, multiple sclerosis and hemophilia. Prior to that, he worked at Bristol-Myers Squibb Company (NYSE: BMY) from August 2001 to June 2011 in various roles within clinical development and medical affairs. Dr. Rakhit ultimately served as vice president of the international medical organization with oversight of the medical teams in more than 25 countries across North and South America, Australia, the Middle East, Africa and the Pacific Rim. Dr. Rakhit earned his Bachelor of Arts in Molecular and Cell Biology from the University of California, Berkeley, his medical degree from Tufts University School of Medicine, his Master of Science from Vanderbilt University School of Medicine and his Master of Business Administration from Columbia University and London Business School. Dr. Rakhit completed his fellowship in pediatric cardiology at Harvard Medical School and practiced as part of the pediatric cardiac transplant service at Boston Children’s Hospital prior to joining the industry. Dr. Rakhit currently is an advisory trustee for the Liberty Science Center in Jersey City, New Jersey, and a healthcare advisor for the Partnership for NYC.